Host Immunity and Immunization Strategies for Clostridioides difficile Infection

Area of Science:

• Immunology
• Microbiology
• Public Health

Background:

• Clostridioides difficile infection (CDI) is a major public health concern, designated an urgent threat by the U.S. CDC due to significant mortality and morbidity.
• Recurrence affects up to one-third of CDI patients, often exacerbated by antibiotic use, which is both a primary treatment and a cause of the disease.

Purpose of the Study:

• To review current knowledge on host immune responses (innate and adaptive) against Clostridioides difficile.
• To describe key determinants of CDI, including C. difficile toxins and the host microbiota.
• To discuss existing therapeutic strategies and the status of immunization for CDI.

Main Methods:

• Literature review of scientific articles and clinical studies.
• Synthesis of information on immune mechanisms, microbial interactions, and treatment outcomes.
• Analysis of current therapeutic and immunization approaches for CDI.

Main Results:

• The review details the complexities of innate and adaptive immunity in the context of CDI.
• It highlights the roles of C. difficile toxins and the gut microbiota in disease pathogenesis.
• Current therapeutic options and emerging immunization strategies are discussed.

Conclusions:

• Understanding host-pathogen interactions and immune responses is crucial for developing effective CDI therapies.
• Addressing antibiotic-induced dysbiosis and exploring novel treatment modalities, including vaccines, are key research directions.
• This review aims to bridge knowledge gaps for improved CDI management and prevention.